LOS ANGELES - TelAve -- LOS ANGELES, CA –– BEP Holdings announced today that its CEO, Ben Pouladian (LinkedIn (https://www.linkedin.com/in/benpouladian), X (https://x.com/benitoz)), will be a featured panelist at the ISPE Greater Los Angeles Area Chapter's upcoming "Resilient Life Sciences Ecosystem & Continuous Drug Discovery" program on July 9, 2025 (see LinkedIn panel announcement (https://www.linkedin.com/)). The International Society for Pharmaceutical Engineering (ISPE) Greater LA Chapter event, hosted at JLL's downtown Los Angeles office, will convene industry leaders to discuss strengthening biomanufacturing and life sciences innovation in the region.

Pouladian is an engineer-turned-entrepreneur and investor who leads BEP Holdings, a firm focused on life science ventures and infrastructure. Under his leadership, BEP Holdings has helped create much-needed lab space for technological research and development in the local biotech community , bridging critical infrastructure gaps in Los Angeles's life science sector. Pouladian also serves on the Leadership Board of the Terasaki Institute for Biomedical Innovation , a nonprofit research organization, reflecting his commitment to advancing medical research and innovation.

More on TelAve News

• Artbound: "The Cheech" Awarded Two 2025 LA Area EMMY Awards — Honored in ARTS & MUSIC COMPOSITION
• Rising Conservative Star Jordan Brace Emerges as Influential Political Voice with Elite Washington Connections
• Conservative Latinos for PA Shaping the Future of Hispanic Community, Guest State Treasurer Stacy Garrity
• Chasing Creative Plants Roots in Palm Coast, Builds Marketing Systems for Modern B2B Brands
• David M. White, DDS Celebrates 500 Five-Star Reviews in Reno

Pouladian's dedication to the life sciences is deeply personal. He lost his father to liver cancer and later his mother to non-small cell lung cancer —experiences that galvanized his mission to support life-saving innovations in healthcare. "After losing both my parents to cancer, I made it my mission to help advance better outcomes and therapies for others," said Pouladian. "By investing in innovative biotech companies and critical lab infrastructure, we can accelerate the development of new treatments so that families don't have to endure what mine did."

About BEP Holdings: BEP Holdings is a Los Angeles-based private investment firm dedicated to fostering innovation in life sciences and advanced technologies. The firm invests in early-stage biotech and pharmaceutical ventures and develops state-of-the-art laboratory facilities to support cutting-edge research. Under the leadership of CEO Ben Pouladian, BEP Holdings aims to accelerate the development of life-saving therapies by bridging gaps in resources and infrastructure within Southern California's life science ecosystem.